Several points concerning the introduction of CYD-TDV were highlighted by the Americas Dengue Prevention Board. We invite you to read more about the issues relating to dengue vaccine introduction in light of the WHO position.
Mexico City, Mexico – August 31, 2016 – Today, four leading institutions at the forefront of dengue prevention and control—the International Vaccine Institute (IVI), the International Vaccine Access Center (IVAC) of the Johns Hopkins University, the Partnership for Dengue Control Foundation (PDC) and the Sabin Vaccine Institute—announced a new global alliance to integrate approaches to fight dengue and other Aedes-transmitted diseases under one strategic umbrella....
PAHO, DVI and Sabin provide an open forum to discuss the future of dengue
Dr. Yoon, former Chief of the Department of Virology, Armed Forces Research Institute Medical Sciences in Bangkok, Thailand, will lead DVI starting August, 2015.
One year has passed since we said goodbye to Dr. Ciro de Quadros, Sabin Vaccine Institute’s former Executive Vice President and Director of our Vaccine Advocacy and Education program. Best known for his tireless work to...
DVI is delighted to announce the appointment of Professor Annelies Wilder-Smith as Senior Advisor to the DVI, effective immediately.
Thursday, May 29, 2014
Dr. Ciro de Quadros, a public health hero and the Sabin Vaccine Institute’s Executive Vice President and Director of Vaccine Advocacy and Education, passed away peacefully yesterday at his home in Washington, DC, surrounded by his family. The following are statements from Sabin’s executive leadership reflecting on the profound difference that Ciro made during his lifetime.
Six dengue vaccine candidates are in various stages of clinical development but developing countries will not receive the benefits if planning does not start now.